Feedback
Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance (PhenoSense GT Plus Integrase)
2010808
Ordering Recommendation

HIV-1 combined pheno- and genotyping test provides antiretroviral susceptibility information for protease inhibitors (PI), reverse transcriptase inhibitors (NRTI, NNRTI), and integrase inhibitors (INI). Preferred test for patients with known or suspected complex drug resistance patterns (eg, suboptimal virologic response to treatment and viral load rebound).

Mnemonic
PHENO PLUS
Methodology
Phenotyping/Genotyping
Performed
Varies
Reported
16-21 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA) or plasma preparation tube (PPT). 
Specimen Preparation
Separate plasma from cells within 6 hours of collection. Transfer 5 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 3 mL) 
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. 
Unacceptable Conditions
Thawed specimens. 
Remarks
Provide patient's most recent viral load and viral load collection date. 
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen at -20°C: 2 weeks; Frozen at -70°C: Indefinitely 
Reference Interval
By report
Interpretive Data


Note
Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
CPT Code(s)
87900; 87901; 87903; 87904 x 14; 87906
Components
Component Test Code*Component Chart NameLOINC
0092073Viral Load8251-1
0092074Viral Load Date19151-0
2010809EER HIV-1 PhenoSense GT Plus Integrase
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases

Performed at Monogram Biosciences